TY - JOUR
T1 - Aminoglycoside Effects on Voltage-Sensitive Calcium Channels and Neurotoxicity
AU - Wagner, John A.
AU - Snowman, Adele M.
AU - Olivera, Baldomero M.
AU - Snyder, Solomon H.
PY - 1987/12/24
Y1 - 1987/12/24
N2 - To the Editor: Since ototoxicity and neuromuscular toxicity of aminoglycoside antibiotics are reversed by calcium,1,2 and presynaptic events appear to be involved in aminoglycoside-induced neuromuscular blockade,3,4 we suspected a role for voltage-sensitive calcium channels in aminoglycoside neurotoxicity. Among the several subtypes of those channels, the N-channel is predominantly involved in neurotransmitter release.5 6 7 We investigated the influences of therapeutic concentrations of aminoglycosides on N-channels monitored by either 45Ca2+ uptake or binding of the calcium-channel toxin [125I]omega-conotoxin GV IA, which predominantly labels N-channels in neuronal membranes.8 Aminoglycosides inhibit brain neuronal and sympathetic-ganglia–membrane binding of [125I]conotoxin, and relative potencies correlate closely…, No extract is available for articles shorter than 400 words.
AB - To the Editor: Since ototoxicity and neuromuscular toxicity of aminoglycoside antibiotics are reversed by calcium,1,2 and presynaptic events appear to be involved in aminoglycoside-induced neuromuscular blockade,3,4 we suspected a role for voltage-sensitive calcium channels in aminoglycoside neurotoxicity. Among the several subtypes of those channels, the N-channel is predominantly involved in neurotransmitter release.5 6 7 We investigated the influences of therapeutic concentrations of aminoglycosides on N-channels monitored by either 45Ca2+ uptake or binding of the calcium-channel toxin [125I]omega-conotoxin GV IA, which predominantly labels N-channels in neuronal membranes.8 Aminoglycosides inhibit brain neuronal and sympathetic-ganglia–membrane binding of [125I]conotoxin, and relative potencies correlate closely…, No extract is available for articles shorter than 400 words.
UR - http://www.scopus.com/inward/record.url?scp=0023502283&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023502283&partnerID=8YFLogxK
U2 - 10.1056/NEJM198712243172617
DO - 10.1056/NEJM198712243172617
M3 - Letter
C2 - 2446133
AN - SCOPUS:0023502283
SN - 0028-4793
VL - 317
SP - 1669
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 26
ER -